All News #Library
Biotech
Crystalys Therapeutics Names Thacker CFO for Dotinurad Phase 3
21 Jan 2026 //
PR NEWSWIRE
Fortress, Urica Dose First Patients In Ph3 Dotinurad Gout Trial
21 Oct 2025 //
GLOBENEWSWIRE
Crystalys Therapeutics Progresses Dotinurad Phase 3 Trials
21 Oct 2025 //
PR NEWSWIRE
Fortress Biotech And Urica Therapeutics Unveil Crystalys
01 Oct 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support